Noop. Not much chance of either of those really having a materially substantial difference. Next big catalyst for GBSN will be FDA approval of the 8/31/15 510 (k) filing. Theoretically, that should be around 6-7 more weeks from now. http://ih.advfn.com/p.php?pid=nmona&article=68346720